KS KEWAUNEE SCIENTIFIC CORP /DE/ Stock: price and insider trades · United States · SEC (Form 4)Track the KEWAUNEE SCIENTIFIC CORP /DE/ share price and the full directors' dealings record of the company, a publicly traded company based in United States. Shares are listed on the US market, under the supervision of SEC (Form 4). Operating in the Industry sector, KEWAUNEE SCIENTIFIC CORP /DE/ has logged 99 insider filings. Market capitalisation: €108.4m. The latest transaction was disclosed on 2 July 2026 (Levée d'options). Among the most active insiders: HULL THOMAS DAVID III. Every trade is accessible without an account.
This score ranks the purchase within its own market. No market currently meets the historical allocation criteria, so signals remain watch-only. Not investment advice.
Fundamental score
Ranked 3,980 of 29,064 companies
FCF yld 14%
Earn yld 8.9%
EV/EBITDA 5.8x
ROE 15%
Gross mgn 29%
Net mgn 3.4%
Debt/EBITDA 1.3x
Pillars 2/3
Transparent value + quality ranking, distinct from the insider signal.
Σ Sigma AI Analysis Fundamental view, insider signal, bull and bear case, synthesis.
AI analysis generation is paused.
Last declaration on 2 July 2026
All Executives99 Thresholds0 Prospectus0 Other0
Declarations 99 total
◇ SVP, Manufacturing Operations · Executives · 30 Jun 2026
7,451 shares Common Stock SEC:0001814145-26-000004:0
● SVP, Manufacturing Operations · Executives · 30 Jun 2026
5,609 shares Common Stock SEC:0001814145-26-000004:1
● SVP, Manufacturing Operations · Executives · 30 Jun 2026
851 shares Common Stock SEC:0001814145-26-000004:2
● Director · Executives · 26 Mar 2026
2,750 shares 0Common Stock SEC:0001261869-26-000002:0
▼ President, CEO · Executives · 7 Jan 2026
2,177 shares @ US$37.50 8.1% of flow Common Stock SEC:0001657070-26-000004:0
▼ Chief Financial Officer · Executives · 6 Jan 2026
2,000 shares @ US$37.57 12.3% of flow Common Stock SEC:0001775052-26-000002:0
▼ President, CEO · Executives · 30 Dec 2025
29 shares @ US$38.00 0.1% of flow Common Stock SEC:0001657070-26-000002:0
▼ President, CEO · Executives · 29 Dec 2025
884 shares @ US$38.01 3.3% of flow Common Stock SEC:0001657070-25-000026:0
▼ President, CEO · Executives · 22 Dec 2025
1,000 shares @ US$39.00 4.4% of flow Common Stock SEC:0001657070-25-000024:0
▼ President, CEO · Executives · 17 Dec 2025
1,000 shares @ US$39.00 4.6% of flow Common Stock SEC:0001657070-25-000022:0
▼ Chief Financial Officer · Executives · 9 Oct 2025
3,000 shares @ US$42.76 24.2% of flow Common Stock SEC:0001775052-25-000017:0
▼ President, CEO · Executives · 1 Oct 2025
1,000 shares @ US$43.09 5.3% of flow Common Stock SEC:0001657070-25-000020:0
▼ VP - Human Resources · Executives · 2 Oct 2025
6,877 shares @ US$43.20 45.2% of flow Common Stock SEC:0001467437-25-000008:0
▼ President, CEO · Executives · 29 Sept 2025
1,854 shares @ US$43.42 10.5% of flow Common Stock SEC:0001657070-25-000018:0
▼ President, CEO · Executives · 23 Sept 2025
721 shares @ US$44.00 4.1% of flow Common Stock SEC:0001657070-25-000016:0
▼ President, CEO · Executives · 18 Sept 2025
652 shares @ US$46.00 4.5% of flow Common Stock SEC:0001657070-25-000014:0
◆ Director · Executives · 10 Sept 2025
690 shares 0Common Stock SEC:0002084386-25-000004:0
● Director · Executives · 29 Jul 2025
325 shares 0Common Stock SEC:0001261869-25-000006:0
▼ Chief Financial Officer · Executives · 24 Jul 2025
2,096 shares @ US$58.34 29.9% of flow Common Stock SEC:0001775052-25-000012:0
◇ VP of Manufacturing Operations · Executives · 30 Jun 2025
3,058 shares 0Common Stock SEC:0001814145-25-000006:0
◇ VP-Information Technology · Executives · 30 Jun 2025
2,966 shares 0Common Stock SEC:0001795887-25-000004:0
◇ Chief Financial Officer · Executives · 30 Jun 2025
5,697 shares 0Common Stock SEC:0001775052-25-000010:0
◇ VP-Sales & Marketing-Americas · Executives · 30 Jun 2025
2,959 shares 0Common Stock SEC:0001747001-25-000006:0
◇ President, CEO · Executives · 30 Jun 2025
12,130 shares 0Common Stock SEC:0001657070-25-000010:0
◇ VP - Human Resources · Executives · 30 Jun 2025
2,733 shares 0Common Stock SEC:0001467437-25-000004:0
25 of 99 declarations
Load more (74 remaining) 关于 KEWAUNEE SCIENTIFIC CORP /DE/ Kewaunee Scientific Corp /DE/(股票代码:KEQU)是一家在美国纳斯达克上市的美国工业公司。Kewaunee 成立于 1906 年,在实验室、医疗保健和技术家具及基础设施产品的设计、制造和安装方面建立了长期的利基市场。对于法语投资者而言,它最好被视为一家专业的资本货物供应商,其业务与科学、教育、医疗保健和研究设施的结构性支出相关,而非一家广泛的通用制造商。
公司的核心产品包括钢制和木制橱柜、实验室工作台、环氧树脂工作台面和水槽、通风柜、适应性模块化系统、可移动工作站和生物安全柜。除了实体家具产品线,Kewaunee 还提供安装和相关项目服务,这使得其模式比纯粹的产品销售商更加整合。其终端市场涵盖生命科学、教育、政府、医疗保健和一般研究。这种终端市场组合赋予 Kewaunee 一定程度的韧性,因为需求与实验室建设、翻新、合规驱动的升级以及科学基础设施投资相关。
Kewaunee 的总部位于北卡罗来纳州斯泰茨维尔。公司还在美国、印度、沙特阿拉伯和新加坡设有销售办事处,并在斯泰茨维尔和印度班加罗尔设有制造工厂。这一布局赋予 Kewaunee 双重身份:一个以美国为基础的工业基地,同时具有重要的国际影响力,尤其是在亚洲和其他海外市场。公司在印度的本地制造业务也支持区域客户需求,并扩大了其服务北美以外市场的能力。
竞争定位由专业化、技术信誉以及在实验室环境中满足严格安全和质量标准的声誉驱动。Kewaunee 强调与行业机构合作,以帮助制定产品标准,这支持了其作为技术监管利基市场中值得信赖的供应商的定位。最近的发展尤为重要。在 2025 财年,Kewaunee 报告年销售额为 240.5 million 美元,同比增长 18%,同时 EBITDA 表现强劲。一个关键的战略里程碑是 2024 年 11 月 1 日收购 Nu Aire,这扩大了产品组合,涵盖生物安全柜、CO2 培养箱、超低温冰箱和相邻实验室产品。管理层还报告称,截至 2025 年 4 月 30 日,积压订单为 214.6 million 美元,表明近期需求可见性良好。总体而言,KEQU 看起来像一家专注于市场定位、以收购为主导增长、并长期受益于美国及海外实验室资本支出周期的小盘工业复合型公司。